Neutralizing antibodies are known to have a crucial role in protecting against SARS-CoV-2
infection and have been suggested to be a useful correlate of protection for vaccine clinical …

Responsible for more than 4.9 million deaths so far, COVID-19, caused by SARS-CoV-2, is
instigating devastating effects on the global health care system whose impacts could be …

Global case and death incidences continued to decrease with over 3 million new weekly
cases and over 73 000 new deaths, a 15% and an 8% decrease respectively, compared to …

Large-scale vaccination campaigns have prevented countless hospitalizations and deaths
due to COVID-19. However, the emergence of SARS-CoV-2 variants that escape from …

Background Emerging and future SARS-CoV-2 variants may jeopardize the effectiveness of
vaccination campaigns. Therefore, it is important to know how the different vaccines perform …

Importance It has become common practice to offer immunocompromised patients with
hematologic cancers a third COVID-19 vaccination dose, but data substantiating this are …

Summary BNT162b2 and mRNA‐1273 are two types of mRNA‐based vaccine platforms that
have received emergency use authorization. The emergence of novel severe acute …

The ongoing evolution of SARS-CoV-2 has resulted in the emergence of Omicron, which
displays notable immune escape potential through mutations at key antigenic sites on the …

Vaccination guidelines for patients treated for hematological diseases are typically
conservative. Given their high risk for severe COVID-19, it is important to identify those …

Eliciting potent and broadly neutralizing antibodies (bnAbs) is a major goal in HIV-1 vaccine
development. Here, we describe how germline-targeting immunogen BG505 SOSIP …